Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David G. Hunter is active.

Publication


Featured researches published by David G. Hunter.


Cell | 2010

Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance

Max A. Tischfield; Hagit Baris; Chen Wu; G. Rudolph; Lionel Van Maldergem; Wei He; Wai Man Chan; Caroline Andrews; Joseph L. Demer; Richard L. Robertson; David A. Mackey; Jonathan B Ruddle; Bird Td; Irene Gottlob; Christina Pieh; Elias I. Traboulsi; Scott L. Pomeroy; David G. Hunter; Janet S. Soul; Anna Newlin; Louise J. Sabol; Edward J. Doherty; Clara E. de Uzcátegui; Nicolas Uzcategui; Mary Louise Z Collins; Emin Cumhur Sener; Bettina Wabbels; Heide Hellebrand; Thomas Meitinger; Teresa de Berardinis

We report that eight heterozygous missense mutations in TUBB3, encoding the neuron-specific beta-tubulin isotype III, result in a spectrum of human nervous system disorders that we now call the TUBB3 syndromes. Each mutation causes the ocular motility disorder CFEOM3, whereas some also result in intellectual and behavioral impairments, facial paralysis, and/or later-onset axonal sensorimotor polyneuropathy. Neuroimaging reveals a spectrum of abnormalities including hypoplasia of oculomotor nerves and dysgenesis of the corpus callosum, anterior commissure, and corticospinal tracts. A knock-in disease mouse model reveals axon guidance defects without evidence of cortical cell migration abnormalities. We show that the disease-associated mutations can impair tubulin heterodimer formation in vitro, although folded mutant heterodimers can still polymerize into microtubules. Modeling each mutation in yeast tubulin demonstrates that all alter dynamic instability whereas a subset disrupts the interaction of microtubules with kinesin motors. These findings demonstrate that normal TUBB3 is required for axon guidance and maintenance in mammals.


PLOS ONE | 2010

Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia, and Mortality

Saurabh Mehta; Edward Giovannucci; Ferdinand Mugusi; Donna Spiegelman; Said Aboud; Ellen Hertzmark; Gernard I. Msamanga; David G. Hunter; Wafaie W. Fawzi

Background Vitamin D has a potential role in slowing HIV disease progression and preventing mortality based on its extensive involvement in the immune system; however, this relationship has not been examined in large studies or in resource-limited settings. Methodology/Principal Findings Vitamin D levels were assessed in 884 HIV-infected pregnant women at enrollment in a trial of multivitamin supplementation (not including vitamin D) in Tanzania. Women were followed up for a median of 69.5 months, and information on hemoglobin levels, HIV disease progression, and mortality was recorded. Proportional hazard models and generalized estimating equations were used to assess the relationship of these outcomes with vitamin D status. Conclusions/Significance Low vitamin D status (serum 25-hydroxyvitamin D<32ng/mL) was significantly associated with progression to WHO HIV disease stage III or greater in multivariate models (incidence rate ratio [RR]: 1.25; 95% confidence intervals [CI]: 1.05, 1.50). No significant relationship was observed between vitamin D status and T-cell counts during follow-up. Women with low vitamin D status had 46% higher risk of developing severe anemia during follow-up, compared to women with adequate vitamin D levels (RR: 1.46; 95% CI: 1.09, 1.96). Women in the highest vitamin D quintile had a 42% lower risk of all-cause mortality, compared to the lowest quintile (RR: 0.58; 95% CI: 0.40, 0.84). Vitamin D status had a protective association with HIV disease progression, all-cause mortality, and development of anemia during follow-up in HIV-infected women. If confirmed in randomized trials, vitamin D supplementation could represent a simple and inexpensive method to prolonging the time to initiation of antiretroviral therapy in HIV-infected patients, particularly in resource-limited settings.


Ophthalmology | 1993

Diode laser photocoagulation for threshold retinopathy of prematurity: A randomized study

David G. Hunter; Michael X. Repka

BACKGROUND Although peripheral cryotherapy decreases the incidence of unfavorable anatomic outcomes in threshold retinopathy of prematurity (ROP), apnea, bradycardia, and lid edema can occur. Argon laser indirect ophthalmoscope photocoagulation has been used as an alternative to cryotherapy, with fewer adverse effects. Retinal lesions placed with diode lasers are deeper than similar argon laser lesions, and it is not known whether this difference could influence the response to ablative therapy. METHODS Patients were enrolled under a prospective, randomized protocol. One eye of each patient with symmetric, threshold ROP was treated with an 814/815 nm diode laser, while the other eye was treated with cryotherapy. Patients with asymmetric diseases also were randomized for treatment in the threshold eye. RESULTS Nineteen infants (33 eyes) were treated, ranging from 485 to 863 g birth weight (23 to 27 weeks gestational age); 18 patients (32 eyes) were followed for 3 months or longer. Four patients (8 eyes) had bilateral zone 1 disease. Postconceptional age was 36 to 45 weeks at the time of treatment. The diode laser treatment was better tolerated than cryotherapy, and the treatment apparatus was more easily transported. Apneic episodes requiring intubation resulted from two cryotherapy sessions but no diode laser sessions. Five cryotherapy-treated eyes required retreatment because of persistent disease with adjacent skip areas. In the group followed for 3 to 15 months, 1 cryotherapy-treated eye and 1 diode laser-treated eye progressed to stage 5 retinal detachment. CONCLUSION Compared with cryotherapy, the diode laser was more convenient, technically easier to administer, and better tolerated by the patient. Although the number of patients was too small for meaningful statistical analysis of outcome, diode laser peripheral retinal ablation appeared to be as effective as cryotherapy for the treatment of threshold ROP.


Nature Genetics | 2006

Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus

Patrick Tarpey; Shery Thomas; N. Sarvananthan; Uma Mallya; Steven Lisgo; Christopher J. Talbot; Eryl O. Roberts; Musarat Awan; Mylvaganam Surendran; Rebecca J. McLean; Robert D. Reinecke; Andrea Langmann; Susanne Lindner; Martina Koch; Sunila Jain; Geoffrey Woodruff; Richard P. Gale; Chris Degg; Konstantinos Droutsas; Ioannis Asproudis; Alina A. Zubcov; Christina Pieh; Colin D. Veal; Rajiv D. Machado; Oliver C. Backhouse; Laura Baumber; Cris S. Constantinescu; Michael C. Brodsky; David G. Hunter; Richard W. Hertle

Idiopathic congenital nystagmus is characterized by involuntary, periodic, predominantly horizontal oscillations of both eyes. We identified 22 mutations in FRMD7 in 26 families with X-linked idiopathic congenital nystagmus. Screening of 42 singleton cases of idiopathic congenital nystagmus (28 male, 14 females) yielded three mutations (7%). We found restricted expression of FRMD7 in human embryonic brain and developing neural retina, suggesting a specific role in the control of eye movement and gaze stability.


PLOS ONE | 2010

Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome

Juliet A. Moncaster; Roberto Pineda; Robert D. Moir; Suqian Lu; Mark A. Burton; Joy G. Ghosh; Maria Ericsson; Stephanie J. Soscia; Anca Mocofanescu; Rebecca D. Folkerth; Richard M. Robb; Jer R. Kuszak; John I. Clark; Rudolph E. Tanzi; David G. Hunter; Lee E. Goldstein

Down syndrome (DS, trisomy 21) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans. In DS, triplication of chromosome 21 invariably includes the APP gene (21q21) encoding the Alzheimers disease (AD) amyloid precursor protein (APP). Triplication of the APP gene accelerates APP expression leading to cerebral accumulation of APP-derived amyloid-β peptides (Aβ), early-onset AD neuropathology, and age-dependent cognitive sequelae. The DS phenotype complex also includes distinctive early-onset cerulean cataracts of unknown etiology. Previously, we reported increased Aβ accumulation, co-localizing amyloid pathology, and disease-linked supranuclear cataracts in the ocular lenses of subjects with AD. Here, we investigate the hypothesis that related AD-linked Aβ pathology underlies the distinctive lens phenotype associated with DS. Ophthalmological examinations of DS subjects were correlated with phenotypic, histochemical, and biochemical analyses of lenses obtained from DS, AD, and normal control subjects. Evaluation of DS lenses revealed a characteristic pattern of supranuclear opacification accompanied by accelerated supranuclear Aβ accumulation, co-localizing amyloid pathology, and fiber cell cytoplasmic Aβ aggregates (∼5 to 50 nm) identical to the lens pathology identified in AD. Peptide sequencing, immunoblot analysis, and ELISA confirmed the identity and increased accumulation of Aβ in DS lenses. Incubation of synthetic Aβ with human lens protein promoted protein aggregation, amyloid formation, and light scattering that recapitulated the molecular pathology and clinical features observed in DS lenses. These results establish the genetic etiology of the distinctive lens phenotype in DS and identify the molecular origin and pathogenic mechanism by which lens pathology is expressed in this common chromosomal disorder. Moreover, these findings confirm increased Aβ accumulation as a key pathogenic determinant linking lens and brain pathology in both DS and AD.


PubMed | 2006

Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.

Patrick Tarpey; Shery Thomas; N. Sarvananthan; Uma Mallya; Steven Lisgo; Christopher J. Talbot; Eryl O. Roberts; Musarat Awan; Mylvaganam Surendran; R. J. McLean; Robert D. Reinecke; Andrea Langmann; Susanne Lindner; Martina Koch; Sunila Jain; Geoffrey Woodruff; Richard P. Gale; Andrew Bastawrous; Christopher Degg; Konstantinos Droutsas; Ioannis Asproudis; Alina A. Zubcov; Christina Pieh; Colin D. Veal; Rajiv D. Machado; Oliver C. Backhouse; L Baumber; Cris S. Constantinescu; Michael C. Brodsky; David G. Hunter

Idiopathic congenital nystagmus is characterized by involuntary, periodic, predominantly horizontal oscillations of both eyes. We identified 22 mutations in FRMD7 in 26 families with X-linked idiopathic congenital nystagmus. Screening of 42 singleton cases of idiopathic congenital nystagmus (28 male, 14 females) yielded three mutations (7%). We found restricted expression of FRMD7 in human embryonic brain and developing neural retina, suggesting a specific role in the control of eye movement and gaze stability.


Ophthalmology | 2001

Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity.

Cameron F. Parsa; Eduardo Silva; Olof H. Sundin; Morton F. Goldberg; M.Robert De Jong; Janet S. Sunness; Ran Zeimer; David G. Hunter

PURPOSE To report ocular and renal findings specific to the inheritable entity called papillorenal (also known as renal-coloboma) syndrome and relate these to a common cause. DESIGN Observational case series and genetic study. PARTICIPANTS Two unrelated probands presenting with absent central retinal vessels and 11 available family members. TESTING Doppler ultrasonographic imaging of the optic nerves and kidneys, fluorescein angiography, and genetic testing for PAX2 mutations were performed. In selected cases, indocyanine green angiography, scanning laser ophthalmoscope perimetry, Retinal Thickness Analyzer measurements, visual evoked potentials, and magnetic resonance imaging were also performed. MAIN OUTCOME MEASURES Better defined characteristics of the papillorenal syndrome. RESULTS Numerous cilioretinal vessels were present with rudimentary or absent central retinal vessels. Superonasal visual field defects, typical for papillorenal syndrome, corresponded to inferotemporal areas of anomalous retinal and choroidal perfusion and hypoplastic retina. Renal hypoplasia was discovered in two affected members of one family (with previously unsuspected renal failure in one case), and recurrent pyelonephritis was discovered in four affected members of the other family. No PAX2 mutations were detected. CONCLUSIONS In the papillorenal syndrome, the hereditary absence of central retinal vessels may be missed, leading to confusion with isolated coloboma, low-tension glaucoma, and morning glory anomaly. Greater awareness of this syndrome will avoid unneeded glaucoma therapy, allow earlier recognition of renal diseases, and allow genetic counseling. We propose that the papillorenal syndrome is a primary dysgenesis that causes vascular abnormalities predominantly affecting the eye, kidney, and urinary tract, leading to hypoplasia of these structures. The absence of defects in the PAX2 gene in these families suggests that mutations in other genes may also be responsible for this syndrome.


Applied Optics | 1999

Automated detection of foveal fixation by use of retinal birefringence scanning

David G. Hunter; Saurabh N. Patel; David L. Guyton

Foveal fixation was monitored in normal subjects remotely and continuously by use of a noninvasive retinal scan. Polarized infrared light was imaged onto the retina and scanned in a 3 degrees annulus at 44 Hz. Reflections were analyzed by differential polarization detection. In all 32 eyes studied, the detected signal was predominantly 88 Hz during central fixation (within +/-1 degree) and 44 Hz during paracentral fixation. Phase shift at 44 Hz correlated with the direction of eye displacement. Potential applications of this technique include screening for eye disease, eye position monitoring during clinical procedures, and use of eye fixation to operate devices.


Ophthalmology | 1999

A proposed simple method for measurement in the anterior chamber angle: biometric gonioscopy

Nathan Congdon; George L. Spaeth; James J. Augsburger; James M. Klancnik; Ketan Patel; David G. Hunter

OBJECTIVE To design a system of gonioscopy that will allow greater interobserver reliability and more clearly defined screening cutoffs for angle closure than current systems while being simple to teach and technologically appropriate for use in rural Asia, where the prevalence of angle-closure glaucoma is highest. DESIGN Clinic-based validation and interobserver reliability trial. PARTICIPANTS Study 1: 21 patients 18 years of age and older recruited from a university-based specialty glaucoma clinic; study 2: 32 patients 18 years of age and older recruited from the same clinic. INTERVENTION In study 1, all participants underwent conventional gonioscopy by an experienced observer (GLS) using the Spaeth system and in the same eye also underwent Scheimpflug photography, ultrasonographic measurement of anterior chamber depth and axial length, automatic refraction, and biometric gonioscopy with measurement of the distance from iris insertion to Schwalbes line using a reticule based in the slit-lamp ocular. In study 2, all participants underwent both conventional gonioscopy and biometric gonioscopy by an experienced gonioscopist (NGC) and a medical student with no previous training in gonioscopy (JK). MAIN OUTCOME MEASURES Study 1: The association between biometric gonioscopy and conventional gonioscopy, Scheimpflug photography, and other factors known to correlate with the configuration of the angle. Study 2: Interobserver agreement using biometric gonioscopy compared to that obtained with conventional gonioscopy. RESULTS In study 1, there was an independent, monotonic, statistically significant relationship between biometric gonioscopy and both Spaeth angle (P = 0.001, t test) and Spaeth insertion (P = 0.008, t test) grades. Biometric gonioscopy correctly identified six of six patients with occludable angles according to Spaeth criteria. Biometric gonioscopic grade was also significantly associated with the anterior chamber angle as measured by Scheimpflug photography (P = 0.005, t test). In study 2, the intraclass correlation coefficient between graders for biometric gonioscopy (0.97) was higher than for Spaeth angle grade (0.72) or Spaeth insertion grade (0.84). CONCLUSION Biometric gonioscopy correlates well with other measures of the anterior chamber angle, shows a higher degree of interobserver reliability than conventional gonioscopy, and can readily be learned by an inexperienced observer.


American Journal of Human Genetics | 2012

HOXB1 Founder Mutation in Humans Recapitulates the Phenotype of Hoxb1−/− Mice

Bryn D. Webb; Sherin Shaaban; Harald Gaspar; Luis F. Cunha; Christian Schubert; Ke Hao; Caroline D. Robson; Wai Man Chan; Caroline Andrews; Sarah MacKinnon; Darren T. Oystreck; David G. Hunter; Anthony J. Iacovelli; Xiaoqian Ye; Anne Camminady; Elizabeth C. Engle; Ethylin Wang Jabs

Members of the highly conserved homeobox (HOX) gene family encode transcription factors that confer cellular and tissue identities along the antero-posterior axis of mice and humans. We have identified a founder homozygous missense mutation in HOXB1 in two families from a conservative German American population. The resulting phenotype includes bilateral facial palsy, hearing loss, and strabismus and correlates extensively with the previously reported Hoxb1(-/-) mouse phenotype. The missense variant is predicted to result in the substitution of a cysteine for an arginine at amino acid residue 207 (Arg207Cys), which corresponds to the highly conserved Arg5 of the homeodomain. Arg5 interacts with thymine in the minor groove of DNA through hydrogen bonding and electrostatic attraction. Molecular modeling and an in vitro DNA-protein binding assay predict that the mutation would disrupt these interactions, destabilize the HOXB1:PBX1:DNA complex, and alter HOXB1 transcriptional activity.

Collaboration


Dive into the David G. Hunter's collaboration.

Top Co-Authors

Avatar

David L. Guyton

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lee E. Goldstein

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Caroline Andrews

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar

Ankoor S. Shah

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Boris I. Gramatikov

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Melanie Kazlas

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge